Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Technology / OptimizeRx Launches NLAB AI Tool
Tech product launch

OptimizeRx Launches NLAB AI Tool

Analysis based on 8 articles · First reported Jun 25, 2026 · Last updated Jun 25, 2026

Sentiment
60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch of NLAB by OptimizeRx is expected to positively impact the company's stock price due to anticipated new recurring revenue streams and an expanded market presence. It will also benefit the broader healthcare technology and pharmaceutical advertising industries by providing more efficient and targeted marketing solutions for life sciences companies and Demand-side platform.

Healthcare Technology Pharmaceuticals Advertising
Event Summary

OptimizeRx, a leading healthcare technology company, announced the launch of its patent-pending Natural Language Audience Builder (NLAB) on June 25, 2026. This AI-powered tool is designed to be embedded within Demand-side platform and agency media planning platforms, enabling life sciences companies and agency marketers to build custom, verified Healthcare Provider (HCP) audiences using natural-language prompts. NLAB combines real-world evidence with proprietary data from OptimizeRx's EHR network to help identify the right providers and activate messages in clinical workflows. This launch expands OptimizeRx's role as an infrastructure partner and is expected to create new recurring revenue streams for the company, with platform integration available from August 2026.

Entities Involved
stock
OptimizeRx
OptimizeRx launched its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool, which is expected to create new recurring revenue streams and expand its role as an infrastructure partner in the life sciences industry.
Importance 100.0 Sentiment 70.0
oth
Demand-side platform
Demand-side platforms (DSPs) are a key integration point for OptimizeRx's NLAB, allowing them to offer differentiated value to pharma and agency clients and potentially increasing their revenue.
Importance 70.0 Sentiment 40.0
oth
List of life sciences
List of life sciences companies will benefit from NLAB by being able to better create and manage custom HCP audiences, leading to more efficient and targeted marketing campaigns.
Importance 70.0 Sentiment 40.0
per
Mike Rousselle
Mike Rousselle, Chief AI Officer at OptimizeRx, commented on the NLAB launch, highlighting its benefits for healthcare marketers in building custom HCP audiences.
Importance 60.0 Sentiment 50.0
per
Steve Silvestro
Steve Silvestro, CEO of OptimizeRx, emphasized the importance of DSPs as a growth channel for OptimizeRx and the value NLAB brings to partners and clients.
Importance 60.0 Sentiment 50.0
govactor
United States — Massachusetts State Police
United States — Massachusetts State Police is the headquarters of OptimizeRx.
Importance 10.0 Sentiment 0.0
Relationships
OptimizeRx related ↔ Steve Silvestro
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.